It was reported during the session that the 30-day results from the TRIOMPHE study are promising for aortic arch treatment in Zone 0 with the NEXUS Aortic Arch Stent-Graft System.

Endospan’s NEXUS TM Aortic Arch Stent Graft System is the first endovascular off-the-shelf system with CE Mark to treat a greatly underserved group of patients diagnosed with a dilative lesion ...